In patients with type 2 diabetes
with high CV risk
with high CV risk
CV DEATH
HAS A
NEW OPPONENT
Jardiance® (empagliflozin) is the only type 2 diabetes pill proven to go beyond lowering A1C to reduce the risk of CV death for adults who have type 2 diabetes and heart disease